Paradigm Biocapital Advisors LP Q1 2023 Filing
Filed May 15, 2023
Portfolio Value
$1055.2T
Holdings
25
Report Date
Q1 2023
Filing Type
13F-HR
All Holdings (25 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | BIIBBIOGEN INC | 349,593 | $97.2T | 9.21% | |
| 2 | INCYINCYTE CORP | 1,261,711 | $91.2T | 8.64% | |
| 3 | LEGNLEGEND BIOTECH CORP | 1,510,324 | $72.8T | 6.90% | |
| 4 | ARGXARGENX SE | 181,172 | $67.5T | 6.40% | |
| 5 | SGENUSDSEAGEN INC | 281,969 | $57.1T | 5.41% | |
| 6 | IMCRIMMUNOCORE HLDGS PLC | 1,126,256 | $55.7T | 5.28% | |
| 7 | ACLXARCELLX INC | 1,757,779 | $54.2T | 5.13% | |
| 8 | VRDNVIRIDIAN THERAPEUTICS INC | 2,085,698 | $53.1T | 5.03% | |
| 9 | MRTXEURMIRATI THERAPEUTICS INC | 1,396,779 | $51.9T | 4.92% | |
| 10 | SNDXSYNDAX PHARMACEUTICALS INC | 2,274,512 | $48.0T | 4.55% | |
| 11 | UTHUNITED THERAPEUTICS CORP DEL | 211,892 | $47.5T | 4.50% | |
| 12 | KROSKEROS THERAPEUTICS INC | 930,752 | $39.7T | 3.77% | |
| 13 | ONCBEIGENE LTD | 184,012 | $39.7T | 3.76% | |
| 14 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 1,595,199 | $38.9T | 3.69% | |
| 15 | BCYCBICYCLE THERAPEUTICS PLC | 1,816,781 | $38.6T | 3.66% | |
| 16 | ASNDASCENDIS PHARMA A/S | 350,866 | $37.6T | 3.57% | |
| 17 | VORVOR BIOPHARMA INC | 6,477,999 | $34.9T | 3.30% | |
| 18 | ZLABZAI LAB LTD | 780,558 | $26.0T | 2.46% | |
| 19 | XENEXENON PHARMACEUTICALS INC | 651,068 | $23.3T | 2.21% | |
| 20 | VRNAVERONA PHARMA PLC | 962,361 | $19.3T | 1.83% | |
| 21 | CRNXCRINETICS PHARMACEUTICALS IN | 1,133,782 | $18.2T | 1.73% | |
| 22 | NVLSEURALPINE IMMUNE SCIENCES INC | 2,317,634 | $17.9T | 1.70% | |
| 23 | —THESEUS PHARMACEUTICALS INC | 1,505,327 | $13.4T | 1.27% | |
| 24 | OLMAOLEMA PHARMACEUTICALS INC | 2,382,377 | $8.3T | 0.78% | |
| 25 | PSTXUSDPOSEIDA THERAPEUTICS INC | 1,072,410 | $3.3T | 0.31% |